Literature DB >> 16034076

The lymphocyte receptor CD6 interacts with syntenin-1, a scaffolding protein containing PDZ domains.

Idoia Gimferrer1, Anna Ibáñez, Montse Farnós, Maria-Rosa Sarrias, Rafael Fenutría, Sandra Roselló, Pascale Zimmermann, Guido David, Jordi Vives, Carles Serra-Pagès, Francisco Lozano.   

Abstract

CD6 is a type I membrane glycoprotein expressed on thymocytes, mature T and B1a lymphocytes, and CNS cells. CD6 binds to activated leukocyte cell adhesion molecule (CD166), and is considered as a costimulatory molecule involved in lymphocyte activation and thymocyte development. Accordingly, CD6 partially associates with the TCR/CD3 complex and colocalizes with it at the center of the mature immunological synapse (IS) on T lymphocytes. However, the signaling pathway used by CD6 is still mostly unknown. The yeast two-hybrid system has allowed us the identification of syntenin-1 as an interacting protein with the cytoplasmic tail of CD6. Syntenin-1 is a PDZ (postsynaptic density protein-95, postsynaptic discs large, and zona occludens-1) domain-containing protein, which functions as an adaptor protein able to bind cytoskeletal proteins and signal transduction effectors. Mutational analyses showed that certain amino acids of the most C-terminal sequence of CD6 (-YDDISAA) and the two postsynaptic density protein-95, postsynaptic discs large, and zona occludens-1 domains of syntenin-1 are relevant to the interaction. Further confirmation of the CD6-syntenin-1 interaction was obtained from pull-down and co-immunoprecipitation assays in mammalian cells. Image analyses also showed that syntenin-1 accumulates at CD6 caps and at the IS. Therefore, we propose that syntenin-1 may function as a scaffolding protein coupling CD6 and most likely other lymphocyte receptors to cytoskeleton and/or signaling effectors during IS maturation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16034076     DOI: 10.4049/jimmunol.175.3.1406

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  Expression of postsynaptic density proteins of the ProSAP/Shank family in the thymus.

Authors:  Peter Redecker; Jürgen Bockmann; Tobias M Böckers
Journal:  Histochem Cell Biol       Date:  2006-06-07       Impact factor: 4.304

2.  Genetic and experimental evidence for the involvement of the CD6 lymphocyte receptor in psoriasis.

Authors:  Marta Consuegra-Fernández; Marc Julià; Mario Martínez-Florensa; Fernando Aranda; Cristina Català; Noelia Armiger-Borràs; María-Teresa Arias; Francisca Santiago; Antonio Guilabert; Anna Esteve; Carlos Muñoz; Carlos Ferrándiz; José-Manuel Carrascosa; Edurne Pedrosa; Jorge Romaní; Mercè Alsina; José-Manuel Mascaró-Galy; Francisco Lozano
Journal:  Cell Mol Immunol       Date:  2017-12-11       Impact factor: 11.530

3.  Syntenin-1 and ezrin proteins link activated leukocyte cell adhesion molecule to the actin cytoskeleton.

Authors:  Cicerone Tudor; Joost te Riet; Christina Eich; Rolf Harkes; Nick Smisdom; Jessica Bouhuijzen Wenger; Marcel Ameloot; Matthew Holt; Johannes S Kanger; Carl G Figdor; Alessandra Cambi; Vinod Subramaniam
Journal:  J Biol Chem       Date:  2014-03-24       Impact factor: 5.157

4.  Syntenin-1 is a new component of tetraspanin-enriched microdomains: mechanisms and consequences of the interaction of syntenin-1 with CD63.

Authors:  Nadya Latysheva; Gairat Muratov; Sundaresan Rajesh; Matthew Padgett; Neil A Hotchin; Michael Overduin; Fedor Berditchevski
Journal:  Mol Cell Biol       Date:  2006-08-14       Impact factor: 4.272

5.  CD6 regulates T-cell responses through activation-dependent recruitment of the positive regulator SLP-76.

Authors:  Namir J Hassan; Stephen J Simmonds; Nicholas G Clarkson; Sarah Hanrahan; Michael J Puklavec; Martine Bomb; A Neil Barclay; Marion H Brown
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

6.  The PDZ-adaptor protein syntenin-1 regulates HIV-1 entry.

Authors:  Mónica Gordón-Alonso; Vera Rocha-Perugini; Susana Álvarez; Olga Moreno-Gonzalo; Angeles Ursa; Soraya López-Martín; Nuria Izquierdo-Useros; Javier Martínez-Picado; Maria Ángeles Muñoz-Fernández; María Yáñez-Mó; Francisco Sánchez-Madrid
Journal:  Mol Biol Cell       Date:  2012-04-25       Impact factor: 4.138

7.  Rationale for Targeting CD6 as a Treatment for Autoimmune Diseases.

Authors:  Ruby Alonso-Ramirez; Séverine Loisel; Caroline Buors; Jacques-Olivier Pers; Enrique Montero; Pierre Youinou; Yves Renaudineau
Journal:  Arthritis       Date:  2011-02-10

8.  CD6 attenuates early and late signaling events, setting thresholds for T-cell activation.

Authors:  Marta I Oliveira; Carine M Gonçalves; Mafalda Pinto; Stéphanie Fabre; Ana Mafalda Santos; Simon F Lee; Mónica A A Castro; Raquel J Nunes; Rita R Barbosa; Jane R Parnes; Chao Yu; Simon J Davis; Alexandra Moreira; Georges Bismuth; Alexandre M Carmo
Journal:  Eur J Immunol       Date:  2011-11-28       Impact factor: 5.532

9.  Syntenin is expressed in human follicular dendritic cells and involved in the activation of focal adhesion kinase.

Authors:  Whajung Cho; Hyeyoung Kim; Jeong-Hyung Lee; Seung Hee Hong; Jongseon Choe
Journal:  Immune Netw       Date:  2013-10-26       Impact factor: 6.303

10.  CD6 modulates thymocyte selection and peripheral T cell homeostasis.

Authors:  Marc Orta-Mascaró; Marta Consuegra-Fernández; Esther Carreras; Romain Roncagalli; Amado Carreras-Sureda; Pilar Alvarez; Laura Girard; Inês Simões; Mario Martínez-Florensa; Fernando Aranda; Ramón Merino; Vanesa-Gabriela Martínez; Rubén Vicente; Jesús Merino; Adelaida Sarukhan; Marie Malissen; Bernard Malissen; Francisco Lozano
Journal:  J Exp Med       Date:  2016-07-04       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.